Bioeffective krill oil compositions
US-9119864-B2 · Sep 1, 2015 · US
Method of reducing appetite in a human subject comprising administering krill oil composition
US9730966B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9730966-B2 |
| Application number | US-201514968183-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 14, 2015 |
| Priority date | Mar 28, 2007 |
| Publication date | Aug 15, 2017 |
| Grant date | Aug 15, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. Further, a method of reducing appetite in humans by administering a krill oil composition is also disclosed.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of reducing appetite in a human subject in need thereof comprising: administering to the human subject an effective amount of a krill oil composition, said krill oil composition comprising from about 40% w/w to about 60% w/w total phospholipids, wherein said total phospholipids comprise from about 3% to about 15% ether phospholipids, and said administering is carried out under conditions to reduce the appetite of the human subject. 2. The method of claim 1 , wherein the human subject is obese. 3. The method of claim 1 , wherein the krill oil composition further comprises greater than about 100 mg/kg astaxanthin esters. 4. The method of claim 1 , wherein the krill oil composition further comprises from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in the composition.
Assignees
Inventors
Classifications
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
- A61K35/612Primary
Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles · CPC title
Anorexiants; Antiobesity agents · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9730966B2 cover?
- This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cho…
- Who is the assignee on this patent?
- Aker Biomarine Antarctic As, Aker Biomarine Antartic As
- What technology area does this patent fall under?
- Primary CPC classification A61K35/612. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).